Microbot Medical (MBOT) Earnings (2010 - 2026)
Microbot Medical (MBOT) earnings from Jun 30, 2010 to Mar 31, 2026. The TTM Microbot Medical (MBOT) earnings is -$14M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Microbot Medical (MBOT) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +21.87% |
| 3 Years TTM | +3.46% |
| 5 Years TTM | +8.73% |
| All Time TTM | -0.52% |
Annual Earnings change of Microbot Medical (MBOT)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$3.67M | -72.07% |
| 2025 | -$13M | +14.86% |
| 2024 | -$11M | +6.52% |
| 2023 | -$11M | -18.45% |
| 2022 | -$13M | +16.45% |
| 2021 | -$11M | +23.34% |
| 2020 | -$9.17M | +26.48% |
| 2019 | -$7.25M | -0.14% |
| 2018 | -$7.26M | -4.35% |
| 2017 | -$7.59M | -21.43% |
| 2016 | -$9.66M | +950.00% |
| 2015 | -$920K | -97.19% |
| 2014 | -$33M | +23.83% |
| 2013 | -$26M | -7.20% |
| 2012 | -$28M | +33.57% |
| 2011 | -$21M | -15.49% |
| 2010 | -$25M | -6.62% |
| 2009 | -$27M | N/A |
Comparison Microbot Medical (MBOT) five years earnings CAGR with competitors
Microbot Medical (MBOT) five years earnings CAGR is 8.73%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| MMSI | Merit Medical Systems Inc | 100.79% | +1054.53% |
| POCI | Precision Optics Corp Inc | 83.62% | +857.78% |
| OSUR | Orasure Technologies Inc | 81.42% | +832.59% |
| SMTI | Sanara MedTech Inc | 54.72% | +526.75% |
| GCTK | GlucoTrack Inc | 48.38% | +454.12% |
| NYXH | Nyxoah SA | 41.25% | +372.52% |
| STXS | Stereotaxis Inc | 28.42% | +225.56% |
| RMD | Resmed Inc | 27.15% | +210.99% |
| RGNT | Regentis Biomaterials Ltd | 26.99% | +209.20% |
| ZTEK | Zentek Ltd | 25.33% | +190.17% |
| XRAY | DENTSPLY Sirona Inc | 21.23% | +143.22% |
| LMAT | Lemaitre Vascular Inc | 21.08% | +141.51% |
| ISRG | Intuitive Surgical Inc | 20.48% | +134.63% |
| HBIO | Harvard Bioscience Inc | 19.81% | +126.93% |
| PDEX | Pro-Dex Inc (co) | 14.33% | +64.19% |
| RGEN | Repligen Corp | 10.68% | +22.38% |
| ATR | Aptargroup Inc | 9.76% | +11.78% |
| PLSE | Pulse Biosciences Inc | 5.66% | -35.15% |
| NXGL | Nexgel Inc | 5.49% | -37.11% |
| STVN | Stevanato Group Spa | 5.39% | -38.24% |
| WST | West Pharmaceutical Services Inc | 5.10% | -41.52% |
| ANGO | Angiodynamic Inc | 3.10% | -64.55% |
| UTMD | Utah Medical Products Inc | 0.83% | -90.50% |